The value of whole body positron emission tomography using 1(8)F-flour
o-deoxy-glucose ((18)FDG) in primary work-up and follow-up was evaluat
ed retrospectively in 104 patients with primary or metastatic breast c
ancer. Compared to other imaging methods, FDG-PET sensitivity was supe
rior to sonography, CT or MRT. Another advantage is the possibility of
whole body imaging and the earlier detection of lymph node metastasis
due to the recognition of functional metabolic chanches compared to s
tuctural changes found with conventional imaging methods.